Please assess the completion status of the following clinical trial:

Trial Title: A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male subjects~* BMI between 18 and 30 kg/m2 and Weight ≥ 60 Kg~* Subjects must be either surgically sterilized (vasectomy), or if their partner is of childbearing potential, must use two methods of contraception, one of which must be a barrier method, from the first dose until 3 months after the last dose~* Subject is able and willing to comply with the requirements of the protocol~Exclusion Criteria:~* History of clinically significant disease~* Any illness within the 4 weeks prior to the screening examination~* Any history of alcohol and/or drug of abuse addiction and/or active / past (up to 2 years before screening) nicotine consumption~* Clinically relevant deviation from normal in the physical examination and vital signs at screening or baseline~* Clinically relevant laboratory abnormalities identified at screening or baseline~* Positive tests at screening for HIV I \& II, hepatitis B and/or hepatitis C in both parts or positive tests for Syphilis, HTLV I \& II and Nucleic Acid Test (NAT) for HIV and HBV~* Positive test for urine drugs of abuse or by anamnesis (Barbiturates, Benzodiazepines, Amphetamines, Opiates, Cocaine, Cannabinoids, Methadone, Phencyclidine, and Tricyclic Antidepressants) and/or positive alcohol blood test~* Subjects who have lost or donated in excess of 400 mL of blood within 3 months prior to Day 1 of the study

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Cohort A (Type: EXPERIMENTAL): Each subject will receive a BL-8040 or Placebo on in a randomized double-blind fashion
- Cohort B (Type: EXPERIMENTAL): Each subject will receive a BL-8040 or Placebo on in a randomized double-blind fashion
- Cohort C (Type: EXPERIMENTAL): Each subject will receive a BL-8040 or Placebo on in a randomized double-blind fashion

Based on this trial design, predict the completion outcome and termination type (if applicable).